26 Dec, 10:44 - Indian

SENSEX 78423.33 (-0.06)

Nifty 50 23740.05078125 (0.05)

Nifty Bank 51216.94921875 (-0.03)

Nifty IT 43544.25 (-0.29)

Nifty Midcap 100 56821.3984375 (-0.41)

Nifty Next 50 68877 (0.03)

Nifty Pharma 22516.099609375 (-0.19)

Nifty Smallcap 100 18657.849609375 (-0.40)

26 Dec, 10:44 - Global

NIKKEI 225 39545.55 (1.06)

HANG SENG 20098.29 (1.08)

S&P 6113.75 (0.06)

Login/Signup
LOGIN HERE
Cancel

Tata Chemicals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 500770 | NSE Symbol : TATACHEM | ISIN : INE092A01019 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
10-Oct-2024 17-Oct-2024 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 inter alia to consider and approve the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30 2024. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Tuesday September 24 2024 to Saturday October 19 2024 (both days inclusive). This is for your information and records. Financial Results for second quarter and half year ended September 30, 2024 Financial Results for the second quarter and half year ended September 30, 2024 (As per BSE Announcement Dated on 17/10/2024)
19-Jul-2024 05-Aug-2024 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve Financial Results of the Company for the quarter ended June 30 2024. Results for the quarter ended June 30, 2024 Unaudited Consolidated and Audited Standalone Financial results for the quarter ended June 30, 2024 (As per BSE Announcement Dated on 05/08/2024)
19-Apr-2024 29-Apr-2024 Accounts TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 inter alia to consider and approve i) Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31 2024; and ii) Recommendation of dividend if any for the year ended March 31 2024 for the approval of the shareholders at the ensuing 85th Annual General Meeting of the Company. In accordance with the Tata Code of Conduct for Prevention of Insider Trading framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Monday March 25 2024 to Wednesday May 1 2024 (both days inclusive). Final Dividend & Audited Results (As per BSE Bulletin dated on 19/04/2024) TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 ,inter alia, to consider and approve Update on board meeting (As per BSE Announcement Dated on 24/04/2024) Outcome of Board Meeting - April 29, 2024 1. Financial Results 2. Recommendation of Dividend: The Board has recommended a dividend of ? 15 per share i.e. 150 % for the financial year 2023-24.The dividend, if approved by the members at the ensuing 85th Annual General Meeting (AGM) of the Company, will be paid (subject to deduction of tax at source) within five days of the AGM. 3. Fund Raising: The Board has approved the proposal for raising of funds through issuance of Non-Convertible Debentures (NCDs) on private placement basis, for an amount up to ? 2,000 Crores. The Board also authorized an internal committee, to take all actions in respect of finalization of terms of issuance and allotment of NCDs. Re-appointment of Independent Directors (As Per BSE Announcement Dated on 29.04.2024)
23-Jan-2024 05-Feb-2024 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Monday February 5 2024 inter-alia to consider and approve the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31 2023. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Monday December 25 2023 to Wednesday February 7 2024 (both days inclusive). This is for your information and records. A copy of this intimation is also being made available on the website at www.tatachemicals.com. Financial Results for the third quarter and nine months ended December 31, 2023 (As Per BSE Announcement dated on 05.02.2024)
23-Oct-2023 10-Nov-2023 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended on September 30 2023. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Sunday September 24 2023 to Sunday November 12 2023 (both days inclusive). This is for your information and records. A copy of this intimation is also being made available on the website at www.tatachemicals.com. Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half-year ended September 30, 2023 This has reference to our letter dated October 23, 2023 giving Notice of the Board Meeting to, inter alia, consider and approve the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended on September 30, 2023. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended on September 30, 2023. The Board Meeting commenced at 2 p.m. (lST) and concluded at 4 p.m. (lST). A copy of the said Financial Results together with the Limited Review Report/ Auditors'' Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. (As Per BSE Announcement Dated on 10.11.2023) Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2023 (As Per BSE Announcement dated on 11.11.2023)
25-Jul-2023 07-Aug-2023 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended on June 30 2023. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Saturday June 24 2023 to Wednesday August 9 2023 (both days inclusive). Pursuant to Regulation 30 of the SEBI LODR Regulations we would like to inform that an Analysts Call on the Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30 2023 would be held on Tuesday August 8 2023 dial in details of which are enclosed herewith. This is for your information and records. A copy of this intimation is also being made available on the website at www.tatachemicals.com. TATA CHEMICALS LIMITED has informed BSE about Board Meeting to be held on 07 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. (As Per BSE Announcement Dated on 26.07.2023) Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended on June 30, 2023 This has reference to our letter dated July 25, 2023 giving Notice of the Board Meeting to, inter alia, consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended on June 30, 2023. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended on June 30, 2023. The Board Meeting commenced at 2.30 p.m. (lST) and concluded at 4.15 p.m. (lST). (As Per BSE Announcement Dated on 07.08.2023) Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023 (As Per BSE Announcement dated on 08.08.2023)
23-May-2023 23-May-2023 Change in Directors We wish to inform that the Board of Directors of the Company at its Meeting held today i.e. May 23, 2023, based on the recommendation of the Nomination and Remuneration Committee, have re-appointed Mr. R. Mukundan (DIN: 00778253) as Managing Director & CEO for a further term of 5 (five) years with effect from November 26, 2023 upto November 25, 2028 (both days inclusive), subject to approval of the Members at the forthcoming Annual General Meeting of the Company. The disclosures as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular on Continuous Disclosure Requirements for listed entities (SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015), concerning the above re-appointment are enclosed as Annexure I to this intimation.
21-Apr-2023 03-May-2023 Accounts TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2023 inter alia to consider and approve i) the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2023; and ii) Recommendation of dividend if any for the year ended March 31 2023 for the approval of the shareholders at the ensuing 84th Annual General Meeting of the Company. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Saturday March 25 2023 to Friday May 5 2023 (both days inclusive). Pursuant to Regulation 30 of the SEBI LODR Regulations we would like to inform that an Analysts Call on the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31 2023 would be held on Thursday May 4 2023 dial in details of which are enclosed herewith. This has reference to our letter dated April 21, 2023 giving Notice of the Board Meeting. The Board at its Meeting held today i.e. Wednesday, May 3, 2023 transacted, inter alia, the following: Recommendation of Dividend: Pursuant to Regulation 30 read with Schedule III Part A Para A of the Listing Regulations, the Board has recommended a dividend of 17.50 per share i.e. 175% for the financial year 2022-23 subject to the approval of the shareholders at the ensuing 84th Annual General Meeting of the Company. The Board Meeting commenced at 2.00 p.m. (lST) and concluded at 4.15 p.m. (lST). This has reference to our letter dated April 21, 2023 giving Notice of the Board Meeting. The Board at its Meeting held today i.e. Wednesday, May 3, 2023 transacted, inter alia, the following businesses: 1. Financial Results The Board approved the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023. 2. Unmodified Opinion: BSR & Co. LLP, the Statutory Auditors of the Company, have issued Auditors'' Reports with an unmodified opinion on the Audited Standalone and Consolidated Financial Statements for financial year ended March 31, 2023. This declaration is being made pursuant to Regulation 33(3)(d) of the SEBI Listing Regulations. The Board Meeting commenced at 2.00 p.m. (lST) and concluded at 4.15 p.m. (lST). (As Per BSE Announcement Dated on 03.05.2023)
20-Jan-2023 01-Feb-2023 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended on December 31 2022. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Sunday December 25 2022 to Friday February 3 2023 (both days inclusive). Pursuant to Regulation 30 of the SEBI (LODR) Regulations we would like to inform that an Analysts Call on the Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended on December 31 2022 would be held on Thursday February 2 2023 details of which are enclosed herewith. This is for your information and records. Further to our letter dated January 20, 2023, please find enclosed a copy of the Press Release with regard to the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022. A copy of the Press Release is also being made available on the Company's website at www.tatachemicals.com. This has reference to our letter dated January 20, 2023 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022. The Meeting of the Board of Directors held today commenced at 2.30 p.m. and concluded at 4.00 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. (As Per BSE Announcement Dated on 01/02/2023)
17-Oct-2022 27-Oct-2022 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2022 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Thursday October 27 2022 inter-alia to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ending on September 30 2022. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Saturday September 24 2022 to Saturday October 29 2022 (both days inclusive). Pursuant to Regulation 30 of the SEBI (LODR) Regulations we would like to inform that an Analysts Call on the Audited Standalone and Unaudited Consolidated Financial Results for the second quarter and half year ending on September 30 2022 would be held on Friday October 28 2022 details of which are enclosed herewith. This is for your information and records This has reference to our letter dated October 17, 2022 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half ended September 30, 2022. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half ended September 30, 2022. The Meeting of the Board of Directors held today commenced at 2.30 p.m. and concluded at 4.00 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half ended September 30, 2022. The Meeting of the Board of Directors held today commenced at 2.30 p.m. and concluded at 4.00 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. You are requested to take the same on record. (As Per BSE Announcement Dated on 27.10.2022)
29-Jul-2022 09-Aug-2022 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 inter alia to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ending on June 30 2022. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Friday June 24 2022 to Thursday August 11 2022 (both days inclusive). Pursuant to Regulation 30 of the SEBI (LODR) Regulations we would like to inform that an Analysts Call on the Audited Standalone and Unaudited Consolidated Financial Results for the first quarter ending on June 30 2022 would be held on Wednesday August 10 2022 details of which are enclosed herewith. This is for your information and records. This has reference to our letter dated July 29, 2022 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022. The Meeting of the Board of Directors held today commenced at 2.00 p.m. and concluded at 3.15 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. You are requested to take the same on record. This has reference to our letter dated July 29, 2022 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022. The Meeting of the Board of Directors held today commenced at 2.00 p.m. and concluded at 3.15 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. You are requested to take the same on record. (As Per BSE Announcement Dated on 09.08.2022) The Board of Directors at its Meeting held on August 9, 2022 has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022. As per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the said financial results were published in the following newspapers on August 10, 2022: i. Business Standard (English) ii. The Free Press Journal (English) iii. Navshakti (Marathi) A copy of the results published is attached herewith. These are also being made available on the website of the Company at www.tatachemicals.com. You are requested to take the same on record. (As Per BSE Announcement dated on 10.08.2022)
20-Apr-2022 29-Apr-2022 Accounts TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2022 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company and recommendation of dividend Tata Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 29, 2022, inter alia, has recommended a dividend of Rs. 12.5 per share i.e 125% for the financial yeat 2021-22 subject to the approval of the shareholders at the ensuing 83rd Annual General Meeting of the Company. This has reference to our letter dated April 20, 2022 giving Notice of the Board Meeting to, inter alia, consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2022 and recommendation of dividend, if any, for the financial year ended March 31, 2022. The Board at its Meeting held today, i.e. Friday, April 29, 2022 transacted, inter alia, the following businesses: Financial Results and Annual General Meeting and Recommendation of Dividend Pursuant to Regulation 30(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board has, at its meeting held today, i.e. Friday, April 29, 2022 recommended the re-appointment of B S R & Co. LLP, Chartered Accountants (Firm Registration No. 101248W/W-100022) as the Statutory Auditors of the Company for a second term of 5 (five) consecutive years from the conclusion of the ensuing 83th Annual General Meeting of the Company scheduled to be held on July 6, 2022 till the conclusion of the 88th Annual General Meeting of the Company to be held in the year 2027, subject to the approval of the shareholders of the Company. The above information is also being made available on the website of the Company at www.tatachemicals.com. You are requested to take the same on record. (As Per BSE Announcement Dated on 29.04.2022) This has reference to our letter dated April 29, 2022 enclosing the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2022. Post submission of the results to the Exchanges, an inadvertent error has been noticed in Note no. 5 of the Standalone Audited Financial Results and Consolidated Audited Financial Results wherein the dividend per share for the year 2021 (previous year) has been incorrectly mentioned as ? 11.00 per share instead of ? 10.00 per share. The revised Note no. 5 of the Standalone Audited Financial Results and Consolidated Audited Financial Results should be read as under: '5. The Board of Directors has recommended a final dividend of 125% (2021: 100%) for the financial year 2021-22 i.e. ? 12.5 per share (2021: ? 10.00 per share) which is subject to approval of shareholders.' We sincerely regret the inconvenience caused to you. (As Per BSE Announcement Dated on 03.05.2022)
31-Jan-2022 10-Feb-2022 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2022 inter alia to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31 2021. In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Saturday December 25 2021 to Saturday February 12 2022 (both days inclusive). Pursuant to Regulation 30 of the SEBI (LODR) Regulations we would like to inform that an Analysts Call on the Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ending on December 31 2021 would be held on Friday February 11 2022 details of which are enclosed herewith. This is for your information and records. This has reference to our letter dated January 31, 2022 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2021. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2021. (As Per BSE Announcement Dated on 10/02/2022) The Board of Directors at its Meeting held on February 10, 2022 has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2021. As per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the said financial results were published in the following newspapers on February 11, 2022: i. Business Standard (English) ii. The Free Press Journal (English) iii. Navshakti (Marathi) A copy of the results published is attached herewith. These are also being made available on the website of the Company at www.tatachemicals.com. You are requested to take the same on record. (As Per BSE Announcement dated on 11.02.2022)
19-Oct-2021 27-Oct-2021 Quarterly Results Quarterly Results This has reference to our letter dated October 19, 2021 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2021. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2021. The Meeting of the Board of Directors held today commenced at 2.30 p.m. and concluded at 4.35 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. This has reference to our letter dated October 19, 2021 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2021. Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2021. The Meeting of the Board of Directors held today commenced at 2.30 p.m. and concluded at 4.35 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. (As Per BSE announcement Dated on 27.10.2021)
26-Jul-2021 05-Aug-2021 Quarterly Results TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021. In accordance with the 'Tata Code of Conduct for Prevention of Insider Trading' pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has intimated its Designated Persons regarding the closure of the trading window from Thursday, June 24, 2021 to Saturday, August 7, 2021 (both days inclusive). Pursuant to Regulation 30 of the SEBI LODR Regulations, we would like to inform that an Analysts' Call on the Audited Standalone and Unaudited Consolidated Financial Results for the first quarter ended June 30, 2021 would be held on Friday, August 6, 2021. This is for your information and records. Pursuant to Regulations 30 and 33 of the Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. You are requested to take the same on record. This has reference to our letter dated July 26, 2021 giving Notice of the Board Meeting to consider and approve the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021. Pursuant to Regulations 30 and 33 of the Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today has, inter alia, approved the Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021. The Meeting of the Board of Directors held today commenced at 2.30 p.m. and concluded at 4.15 p.m. A copy of the said Financial Results together with the Auditors'' Report/Limited Review Report is enclosed herewith. These are also being made available on the website of the Company at www.tatachemicals.com. The said results shall be published in one English and one vernacular newspaper as required. You are requested to take the same on record. (As per BSE Announcement Dated on 5/8/2021)
1 2